Most MMR variants identified in CMMRD patients are in the least penetrant Lynch syndrome genes, i.e., PMS2 and MSH6. CMMRD typically presents with haematological, brain, and gastrointestinal cancers in childhood or adolescence, with a median age of onset < 10 years. This evidence concerns the gene MSH6 and Lynch syndrome.